Scalp cooling reduces chemotherapy-induced alopecia

Pioneers in Scalp Cooling

Paxman have been pioneering scalp cooling technology for over a quarter of a century to support patients and minimize hair loss during chemotherapy. Our clinically proven scalp cooling system helps tens of thousands of cancer patients every year, in more than 60 countries worldwide, to retain their hair during chemotherapy.
Together, we make a difference.
Access & Support

Efficacy
and Safety

Efficacy varies based on a series of factors, with the chemotherapy drug regimens being the primary factor. Taxane-based regimens see the highest rates of hair retention, and although anthracycline regimens see a lower level of efficacy, scalp cooling with anthracyclines is still beneficial.
Learn More

Science and Research

The Biological Mechanisms of Scalp Cooling. Biological research on scalp cooling has been focused on exploring the hypothesis that cooling reduces the entry of chemotherapy drugs into human keratinocytes.
Learn More
MDL No. 86975
© Paxman Coolers 2022
Paxman Locations
Changing the face of cancer around the world
Europe
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
France >
Georgia
Germany
Greece
Hungary
Italy
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Republic of Ireland
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
Asia
Armenia
Bangladesh
Hong Kong
India
Indonesia
Japan
Malaysia
Pakistan
Singapore
South Korea
North & South Amercia
Argentina
Brazil
Iraq
Colombia
Dominican Republic
Mexico
Puerto Rico
Uruguay
US Virgin Islands
Venezuela
Middle East
Bahrain
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Qatar
Saudi Arabia
United Arab Emirates
Africa
Morocco
South Africa
Oceania
Australia
New Zealand